SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment

NCT00009919 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Recurrent Renal Cell Cancer
Stage IV Renal Cell Cancer

Interventions

DRUG: semaxanib

Sponsor

National Cancer Institute (NCI)